Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay

Clinical and Vaccine Immunology

Volumn 18, Issue 7, 2011, Pages 1187-1190

  Kavanagh, Owen ^a,b   Estes, Mary K ^a   Reeck, Amanda ^a   Raju, Ravikiran M ^a,c   Opekun, Antone R ^a   Gilger, Mark A ^a   Graham, David Y ^a   Atmar, Robert L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISSOCIATION ENHANCED LANTHANIDE FLUORESCENT IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; FLUOROIMMUNOASSAY; HUMAN; HUMAN EXPERIMENT; IMMUNOLOGICAL PROCEDURES; INTERMETHOD COMPARISON; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; QUANTITATIVE DUPLEX TIME RESOLVED DISSOCIATION ENHANCED LANTHANIDE FLUORESCENT IMMUNOASSAY; QUANTITATIVE DUPLEX TIME RESOLVED FLUORESCENCE ASSAY; RNA VIRUS INFECTION; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEROLOGY;

ANTIBODIES, VIRAL; CALICIVIRIDAE INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUOROIMMUNOASSAY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NORWALK VIRUS; SEROLOGIC TESTS; TIME FACTORS;

EID: 79960143778     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00039-11     Document Type: Article

References (18)

1. Atmar, R. L., and M. K. Estes. 2006. The epidemiologic and clinical importance of norovirus infection. Gastroenterol. Clin. N. Am. 35:275-290.
2. Atmar, R. L., et al. 2008. Norwalk virus shedding after experimental human infection. Emerg. Infect. Dis. 14:1553-1557.
3. Bertolotti-Ciarlet, A., S. E. Crawford, A. M. Hutson, and M. K. Estes. 2003. The 3′ end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J. Virol. 77:11603-11615.
4. Brinker, J. P., et al. 1998. Detection of Norwalk virus and other genogroup 1 human caliciviruses by a monoclonal antibody, recombinant-antigen- based immunoglobulin M capture enzyme immunoassay. J. Clin. Microbiol. 36: 1064-1069.
5. Glass, R. I., U. D. Parashar, and M. K. Estes. 2009. Norovirus gastroenteritis. N. Engl. J. Med. 361:50-59.
6. Graham, D. Y., et al. 1994. Norwalk virus infection of volunteers: new insights based on improved assays. J. Infect. Dis. 170:34-43.
7. Gray, J. J., et al. 1994. Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus. J. Clin. Microbiol. 32:3059-3063.
8. Green, K. Y., J. F. Lew, X. Jiang, A. Z. Kapikian, and M. K. Estes. 1993. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J. Clin. Microbiol. 31:2185-2191.
9. Hardy, M. E., et al. 1996. Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies. Virology 217:252-261.
10. Huhtinen, P., et al. 2005. Synthesis, characterization, and application of Eu(III), Tb(III), Sm(III), and Dy(III) lanthanide chelate nanoparticle labels. Anal. Chem. 77:2643-2648.
11. Jiang, X., M. Wang, D. Y. Graham, and M. K. Estes. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66:6527-6532.
12. Noel, J. S., et al. 1997. Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995. J. Med. Virol. 53:372-383.
13. Parrino, T. A., D. S. Schreiber, J. S. Trier, A. Z. Kapikian, and N. R. Blacklow. 1977. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med. 297:86-89.
14. Reeck, A., et al. 2010. Serological correlate of protection against norovirus-induced gastroenteritis. J. Infect. Dis. 202:1212-1218.
15. Siitari, H., I. Hemmila, E. Soini, T. Lovgren, and V. Koistinen. 1983. Detection of hepatitis B surface antigen using time-resolved fluoroimmunoassay. Nature 301:258-260.
16. Treanor, J. J., X. Jiang, H. P. Madore, and M. K. Estes. 1993. Subclass-specific serum antibody responses to recombinant Norwalk virus capsid antigen (rNV) in adults infected with Norwalk, Snow Mountain, or Hawaii virus. J. Clin. Microbiol. 31:1630-1634.
17. Xu, Y. Y., et al. 1992. Simultaneous quadruple-label fluorometric immunoassay of thyroid-stimulating hormone, 17 alpha-hydroxyprogesterone, immunoreactive trypsin, and creatine kinase MM isoenzyme in dried blood spots. Clin. Chem. 38:2038-2043.
18. Zerwes, H. G., J. C. Peter, M. Link, H. Gubler, and G. Scheel. 2002. A multiparameter screening assay to assess the cytokine-induced expression of endothelial cell adhesion molecules. Anal. Biochem. 304:166-173.